ProLung Announces Results of New Clinical Study At Ribbon Cutting
October 4, 2019
Yesterday, ProLung welcomed Salt Lake City Mayor Jackie Biskupski, partners, dignitaries, and members of Utah’s life sciences community as the company celebrated its move to a new location with a ribbon cutting ceremony.
ProLung CEO, Jared Bauer, addressed guests, announcing that the company’s move to the Labs at Northgate coincided with good news on recent findings from a large clinical validation trial conducted in China on its ProLung Test™. The study, sponsored by ProLung China, will help underpin a future FDA de novo submission (view press release)
Mayor Biskupski, who joined Bauer in cutting the ribbon, also addressed the gathering. The mayor, congratulated ProLung on its new headquarters and praised the important work the company is doing to improve the early detection of lung cancer. “We’re proud to have ProLung in Salt Lake City,” said Mayor Biskupski, “ProLung exemplifies the growing number of innovative life sciences companies that are putting down roots in our city and making a difference in patients’ lives.”
Gary Webster, District Director for U.S. Representative Chris Stewart was also on hand to help mark the occasion. “Congressman Stewart, like many in Utah, have been affected by cancer,” said Webster. “As a member of the Appropriations Committee, he has the ability to support technology development in the life sciences industry. On behalf of Mr. Stewart, I wish ProLung success in fulfilling their mission of early detection of lung cancer.”
Kelvyn Cullimore, president and CEO of BioUtah, noted that Utah’s life sciences industry is one of the fastest growing life sciences industry in the nation. “BioUtah members, such as ProLung, are part of the success and expansion we’re seeing in the state,” he said.
Other speakers at the event included Clark Cahoon from the Governors Office of Economic Development, Julia Pappas from the World Trade Center and Jan Poulsen of LUNGevity who related her compelling personal battle with lung cancer. Also attending the ceremony were Gordon Larsen, director of policy for the Office of Utah Governor, Gary Hebert and Mandee Grant, community outreach director for Senator Mitt Romney.
The study results showed the highest combined sensitivity and specificity values for a non-invasive lung cancer diagnostic solution, which Bauer believes is a big step forward. ProLung’s mission is to ‘make a difference in time’ for lung cancer patients.